Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FTSE 100 movers: AstraZeneca rallies; Severn Trent in the red

(Sharecast News) - London's FTSE 100 was down 0.2% at 8,411.78 in afternoon trade on Tuesday. AstraZeneca rallied as it laid out plans to hit $80bn in revenue by 2030.

Russ Mould, investment director at AJ Bell, said: "Having stepped up to the plate and delivered on its $45 billion revenue goal set a decade earlier, AstraZeneca is now reaching for the stars with a new target to hit $80 billion revenue by 2030. The market liked the bold ambition, sending the shares to the upper part of the FTSE 100 leader board.

"An easy way for AstraZeneca to achieve such a goal would be to go on a spending spree and buy up rival companies. However, AstraZeneca implies it will hit the goal through organic means which would be all the more impressive.

"Chief executive Pascal Soriot is no stranger to controversy over the scale of his pay packet so perhaps he is trying to justify the large renumeration with the new growth plan. Achieving the goal would imply significant value generation for shareholders and no doubt himself given that part of his bonus scheme will be based on company performance.

"Developing new medicines is not an easy task as the success rate is unpredictable. Even when something is approved for commercial sale, there is always the risk of copycat products once patents expire. AstraZeneca needs to spin multiple plates at the same time as it cannot go 'all in' on one area, in case of failure or setback."

Severn Trent was under the cosh after South West Water owner Pennon slashed its dividend by £2.4m following a record fine for illegally dumping sewage into rivers and the sea.

FTSE 100 - Risers

Schroders (SDR) 377.00p 1.78% Flutter Entertainment (DI) (FLTR) 16,525.00p 1.32% AstraZeneca (AZN) 12,188.00p 0.76% Tesco (TSCO) 312.70p 0.74% Reckitt Benckiser Group (RKT) 4,568.00p 0.71% Antofagasta (ANTO) 2,406.00p 0.54% Next (NXT) 9,410.00p 0.45% Imperial Brands (IMB) 1,945.50p 0.31% London Stock Exchange Group (LSEG) 9,356.00p 0.30% Centrica (CNA) 146.60p 0.27%

FTSE 100 - Fallers

easyJet (EZJ) 459.90p -3.16% Smith (DS) (SMDS) 367.00p -2.39% BT Group (BT.A) 129.25p -2.27% RS Group (RS1) 810.50p -2.23% Scottish Mortgage Inv Trust (SMT) 870.00p -2.16% Hikma Pharmaceuticals (HIK) 1,932.00p -2.08% Vodafone Group (VOD) 75.78p -1.79% Prudential (PRU) 790.80p -1.79% Melrose Industries (MRO) 608.00p -1.78% Severn Trent (SVT) 2,588.00p -1.71%

Share this article

Related Sharecast Articles

Broker tips: Wizz Air, Sabre Insurance
(Sharecast News) - Barclays upgraded Wizz Air on Thursday to 'equalweight' from 'underweight' and lifted its price target on the stock to 1,100.0p from 900.0p as it said the decision to exit Abu Dhabi was a "strategic positive".
Director dealings: British Land chairman makes share purchase
(Sharecast News) - British Land revealed on Thursday that chairman William Rucker had acquired 29,000 ordinary shares in the FTSE 250-listed property development and investment company.
US open: Stocks higher as traders assess data, Q2 earnings
(Sharecast News) - Major indices were slightly higher at the opening bell on Thursday as traders digested a number of data points and some more Q2 earnings.
FTSE 100 movers: Diploma surges on outlook upgrade; easyJet tanks
(Sharecast News) - London's FTSE 100 was up 0.4% at 8,963.89 in afternoon trade on Thursday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.